Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance.

about

Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance.

Item

http://www.wikidata.org/entity/Q55090958

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Long-Acting GLP-1 Receptor Ago ...... ardiac Sympatho-Vagal Balance.

@en

Long-Acting GLP-1 Receptor Ago ...... ardiac Sympatho-Vagal Balance.

@nl

type

Item

label

Long-Acting GLP-1 Receptor Ago ...... ardiac Sympatho-Vagal Balance.

@en

Long-Acting GLP-1 Receptor Ago ...... ardiac Sympatho-Vagal Balance.

@nl

prefLabel

Long-Acting GLP-1 Receptor Ago ...... ardiac Sympatho-Vagal Balance.

@en

Long-Acting GLP-1 Receptor Ago ...... ardiac Sympatho-Vagal Balance.

@nl

P1476

Long-Acting GLP-1 Receptor Ago ...... ardiac Sympatho-Vagal Balance.

@en

P2093

Enzo Bonora

http://www.w3.org/2001/XMLSchema#string

Federico Bellavere

http://www.w3.org/2001/XMLSchema#string

Francesca De Santi

http://www.w3.org/2001/XMLSchema#string

Giacomo Zoppini

http://www.w3.org/2001/XMLSchema#string

Giovanni Targher

http://www.w3.org/2001/XMLSchema#string

Isabella Pichiri

http://www.w3.org/2001/XMLSchema#string

Karl Thomaseth

http://www.w3.org/2001/XMLSchema#string

Lorenza Santi

http://www.w3.org/2001/XMLSchema#string

Maddalena Trombetta

http://www.w3.org/2001/XMLSchema#string

Riccardo Rigolon

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology

GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons.

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Heart rate variability. Frequency domain analysis.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt/GSK3b/b-catenin pathway.

Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis.

Autonomic nervous system-dependent and -independent cardiovascular effects of exendin-4 infusion in conscious rats.

Cardiovascular neural regulation explored in the frequency domain.

P304

53-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JS.2017-00300

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marco Dauriz

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29379894

http://www.w3.org/2001/XMLSchema#string

P932

5779107

http://www.w3.org/2001/XMLSchema#string